Terapevt Arkh
-
Comparative Study
[Complex assessment of inhacort effectiveness in bronchial asthma].
To investigate efficiency of inhacort in long-term (6 months to 2 years) treatment of bronchial asthma (BA). ⋯ Inhacort in a dose 1 mg controls BA. 73% of the patients treated outpatiently had no need in hospitalization.
-
Comparative Study
[Significance of antibodies to herpesviridae viruses detectable in rheumatic diseases].
To assay antibodies to cytomegalovirus (CMV), herpes simplex virus type 1 and 2 (HSV-1, HSV-2) and Epstein-Barr virus (EBV) in rheumatic patients and to clarify clinical correlations. ⋯ In differential diagnosis of rheumatic diseases it is necessary to consider possibility of CMV and EBV infections. If these are detected, antiviral measures should be taken.
-
Clinical Trial
[The inhalational glucocorticosteroid Inhacort in the treatment of bronchial asthma: the efficacy of long-term therapy].
The study of efficacy and safety of ingacort in severe and moderate asthma. ⋯ Long-term administration of ingacort in bronchial asthma is safe and effective.
-
Comparative Study
[HLA-antigens and some pathogenetic aspects of reactive arthritis].
Investigation of associations of reactive arthritis (ReA) with histocompatibility antigens class I and II and determination of new approaches to assessment of association ReA with antigen HLA B27. ⋯ In HLA-B27-subjects optimal conditions exist for generalization of obligate parasites and favorable for production of facultative ones. The degree of association of ReA with HLA B27 antigens is dependent on adaptive features of microorganisms appearing in the process of evolution--obligaty and facultativeness of their internal parasitivity.